Rectal Carcinoma — Trials

Rectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

332 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 94
Recruiting: 52
Ph III recruiting: 6
Growth YoY: +8.7%
Industry share: 2%
Top sponsor: City of Hope Medical Center
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02997553	Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery(GASVERT)	completed	Phase 3	744	Institut de Cancérologie de LorraineOTHER	1	Sep 1, 2026	clinicaltrials
NCT02314182	GRECCAR 8: Primary Tumor Resection in Rectal Cancer With Unresectable Metastasis(GRECCAR8)	completed	Phase 3	5	Hospices Civils de LyonOTHER	1	Dec 19, 2025